CROSS (CROSS) 24-Hour Volatility at 64.3%: Significant Fluctuations Driven by Community Promotion and Wallet Development Updates
Bitget Pulse2026/04/11 12:45Volatility Overview
In the past 24 hours, CROSS price rebounded from a low of $0.061164 to a high of $0.1005, currently at $0.079972, with an amplitude of 64.3%. Trading volume has significantly increased. CoinGecko data shows a 24-hour trading volume of about $13.81 million. Binance futures recorded multiple price spikes accompanied by high volume, such as $233K at $0.07344 and $521K at $0.08459.
Brief Analysis of the Abnormal Price Action
• Community promotional activities and wallet development updates have directly driven the price pump. Bitget's report indicates a 43.5% amplitude from a low of $0.059666 to a high of $0.085644.
• CROSS GameChain officially announced the “Grand Unity Governance Vote” to be launched in 4 days, where the community will decide whether the Mainnet 2.0 “Breakpoint” upgrade will proceed on June 1, 2026.
• Gaming ecosystem events provided support, such as MoltyRoyale launching ERC-8004 on-chain features and distributing a 30 $CROSS prize pool, as well as the global release of “SealM on Cross” accompanied by a 780,000 $CROSS token distribution event.
Market Opinions and Outlook
The mainstream community sentiment is bullish. X platform trading signals indicate long positions being entered (e.g., $0.08320 long target $0.0920). CoinGecko news highlights a shift in Mainnet 2.0 participation model towards a node validator narrative. Analysts note the short-term overbought risk and potential pullback, but expectations for the upgrade support a medium- to long-term optimistic outlook.
Note: This analysis is automatically generated by AI based on public data and on-chain monitoring and is for informational reference only.Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Safe Haven Amid AI Crash! Major Pharmaceutical Stocks Approach Historic Highs
Amid concerns over AI capital expenditures, funds are seeking a "certainty premium." State Street Healthcare ETF reached a record high. Eli Lilly and AbbVie are both approaching their historical highest closing prices, while Gilead and Amgen have surged 7.7% and 7.2% respectively over the past five days. Eli Lilly continues to bet on the future through its GLP-1 dominance and 40 M&A deals totaling $20 billion. AbbVie's core drug Skyrizi has shown positive data for its new subcutaneous formulation, which is expected to extend its patent and drive additional sales.
Fed Officials Turn Hawkish: Daly Says Supply Shocks Should No Longer Be "Wait-and-See," Hammack Suggests More Aggressive Rate Hikes May Be Needed if Inflation Expectations Become Entrenched
San Francisco Fed President Daly stated that the traditional "wait and see" approach to supply-side shocks has been abandoned, noting that businesses in her district are tending to pass rising costs on to consumers and that current inflation risks are "skewed fully to the upside." Cleveland Fed President Hammack said that once the public forms an "inflationary mindset," the difficulty of monetary policy regulation will increase significantly, and the required interest rate hikes will then exceed expectations.
Australian Dollar crumbles as job losses shatter RBA rate hike hopes
Over $10 billion in market value evaporated in four trading days as CoreWeave (CRWV.US) debt risks trigger sell-off, but Deutsche Bank sees it as a buying opportunity
Deutsche Bank believes that the recent sell-off of CoreWeave lacks sufficient company fundamentals to justify it, and the sharp price correction has instead created a buying opportunity for investors.
Crypto prices
More
